Inflammatory Activity After Diverse Fertility Treatments
A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received November 9, 2022
- Accepted in final form February 6, 2023
- First Published March 15, 2023.
Author Disclosures
- Edith L. Graham, MD,
- Jennifer B. Bakkensen, MD,
- Annika Anderson, BA,
- Nicola Lancki, MPH,
- Anne Davidson, BS,
- Gina Perez Giraldo, MD,
- Emily S. Jungheim, MD,
- Anna C. Vanderhoff, MD,
- Bridget Ostrem, MD, PhD,
- Evelyn Mok-Lin, MD,
- David Huang, MD,
- Carolyn J. Bevan, MD, MS,
- Dina Jacobs, MD,
- Tamara B. Kaplan, MD,
- Maria K. Houtchens, MD and
- Riley Bove, MD
- Edith L. Graham, MD,
(1) Novartis (2) Horizon Therapeutics (3) Roche Genentech
NONE
None
(1) American College of Physicians, MKSAP question author 2022-2024
NONE
NONE
NONE
(1) Atara Biotherapeutics (2) Tavistock Life Sciences
NONE
NONE
NONE
(1) F. Hoffman-La Roche Ltd
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Jennifer B. Bakkensen, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Annika Anderson, BA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Nicola Lancki, MPH,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Anne Davidson, BS,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Gina Perez Giraldo, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
-National Multiple Sclerosis Society (NMSS)Clinical fellowship grant. July 1st 2021-June 30th, 2022.-Global health institute, Northwestern Medicine, Fellowship grant. July 1st, 2022-June 30th, 2023
NONE
NONE
NONE
NONE
NONE
NONE
- Emily S. Jungheim, MD,
None
NONE
None
1) Fertility and Sterility Reports, Associate Editor, 2019-present2) Fertility and Sterility Science, Editorial Board, 2019-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Institutes of Health: 5R01HD100318, 2022-present
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Anna C. Vanderhoff, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Bridget Ostrem, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH-R25 NS065743, Awardee, 2010-2022NIH-NINDS 2K12NS098482-06, PI, 2022-2023
(1) Harvard Medical School, Boston, MA, USA (2016-2022)
None
NONE
NONE
NONE
NONE
NONE
NONE
- Evelyn Mok-Lin, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- David Huang, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Carolyn J. Bevan, MD, MS,
Ad board for Genentech
NONE
(1) Genentech - compensated travel for speaking at a conference.
NONE
NONE
NONE
NONE
NONE
(1) Genentech
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Dina Jacobs, MD,
1.Biogen2.Genentech3.Novartis4.EMD Serono5.Banner Life Sciences6.Bristol Myers Squibb7.Horizon8.Sanofi Genzyme
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1.Biogen2.Genentech3.Novartis4.EMD Serono
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Tamara B. Kaplan, MD,
None
NONE
None
NONE
NONE
NONE
NONE
Commercial: Served as a one-time consultant for Novartis and Genetech
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Maria K. Houtchens, MD and
Served on a scientific advisory board for EMDSerono, Biogen Idec,Roche Genentech, Sanofi Genzyme, Novartis
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
Compensated non-promotional journal club presentations and slide deck preparations: Novartis (2010), Serono (2019, 2020)
NONE
Roche GenentechBiogen (investigator-initiated research funding)Serono (collaborative agreement research funding)
NONE
NONE
CMSC research study 2019-2020
NONE
NONE
NONE
NONE
NONE
NONE
- Riley Bove, MD
(1) Sanofi Genzyme(2) Novartis(3) EMD Serono(4) Alexion(5) TG Therapeutics(6) Janssen(7) Horizon
NONE
None
NONE
NONE
NONE
NONE
EMD Serono Alexion HorizonJansen TG Therapeutic
NONE
NONE
NONE
(1) Commercial entity, F Hoffmann Laroche(2) Commercial entity, Biogen(3) Commercial entity, Novartis
NIH NLM R01LM013396 Sep 1, 2021 - May 31, 2025Role: PIDOD MSRP CTA Award 2022-2025
(1) UCSF Medical staff (10/2015-current)
(1) National MS Society, Career Transition Award(2) National MS Society, Research Award(3) National MS Society, Harry Weaver Award
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (E.L.G., G.P.G., C.J.B.), Northwestern University, Chicago, IL; Department of Obstetrics and Gynecology (J.B.B., E.S.J.), Division of Reproductive Endocrinology and Infertility, Northwestern University, Chicago, IL; UCSF Weill Institute for the Neurosciences (A.A., B.O., R.B.), Department of Neurology, University of California, San Francisco (UCSF); Division of Biostatistics (N.L.), Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; Feinberg School of Medicine (A.D.), Northwestern University, Chicago, IL; Department of Obstetrics and Gynecology (A.C.V.), Division of Reproductive Endocrinology and Infertility, Brigham and Women's Hospital, Boston, MA; UCSF Center for Reproductive Health (E.M.-L., D.H.), Mission Bay Campus, San Francisco, CA; Department of Neurology (D.J.), University of Pennsylvania, Philadelphia; and Department of Neurology (T.B.K., M.K.H.), Brigham and Women's Hospital, Boston, MA.
- Correspondence
Dr. Graham edith.graham{at}northwestern.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.